Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Palisade Bio
(NASDAQ:PALI)
Intraday
$6.06
-0.17
[-2.73%]
After-Hours
$6.06
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$6.06
-0.17
[-2.73%]
At close: Apr 25
$6.06
0
[0.00%]
PreMarket: 7:51PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Palisade Bio Stock (NASDAQ:PALI)
Palisade Bio Stock (NASDAQ: PALI)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, April 23, 2024
Crude Oil Moves Higher; General Motors Earnings Top Views
Avi Kapoor
-
2 days ago
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
2 days ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
2 days ago
Dow Jumps Over 200 Points; US Services PMI Falls In April
Avi Kapoor
-
2 days ago
Why Palisade Bio Stock Is Up Today
Erica Kollmann
-
2 days ago
US Stocks Higher; PepsiCo Posts Upbeat Earnings
Avi Kapoor
-
2 days ago
Palisade Bio shares are trading higher after the company's entered a collaboration with Strand Life Sciences.
Benzinga Newsdesk
-
2 days ago
Palisade Bio Enters Collaboration With Strand Life Sciences Aimed At Advance Precision Medicine Approach; Collaboration Provides Palisade Bio Access To Advanced Bioinformatics Tools
Benzinga Newsdesk
-
2 days ago
Wednesday, April 17, 2024
Looking Into Palisade Bio's Recent Short Interest
Benzinga Insights
-
Apr 17, 2024, 10:45AM
Tuesday, April 16, 2024
S&P 500 Edges Lower; PacBio Shares Plunge
Avi Kapoor
-
Apr 16, 2024, 2:30PM
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Apr 16, 2024, 2:17PM
Maxim Group Maintains Buy on Palisade Bio, Adjusts Price Target To $22.5 (reverse stock split 1:15)
Benzinga Newsdesk
-
Apr 16, 2024, 1:27PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Apr 16, 2024, 12:31PM
Gold Moves Higher; Morgan Stanley Earnings Top Views
Avi Kapoor
-
Apr 16, 2024, 12:11PM
Why Palisade Bio Stock Is Soaring Today
Erica Kollmann
-
Apr 16, 2024, 11:47AM
Palisade Bio Shares Resume Trade
Benzinga Newsdesk
-
Apr 16, 2024, 9:49AM
Dow Gains Over 100 Points; Bank of America Posts Upbeat Profit
Avi Kapoor
-
Apr 16, 2024, 9:48AM
Palisade Bio Shares Halted On Circuit Breaker To The Downside, Stock Now Up 96.6%
Benzinga Newsdesk
-
Apr 16, 2024, 9:45AM
Palisade Bio shares are trading higher after the company announced the completion of analysis evaluating ex-vivo bioactivation of PALI-2108.
Benzinga Newsdesk
-
Apr 16, 2024, 8:53AM
Palisade Bio Announces Completion Of Analysis Evaluating Ex-Vivo Bioactivation Of PALI-2108
Benzinga Newsdesk
-
Apr 16, 2024, 8:32AM
Wednesday, April 10, 2024
Palisade Bio Presents Development Overview Of PALI-2108 At The IBD Innovate: Product Development For Crohn's & Colitis April 9-10, 2024 In Cambridge, MA
Benzinga Newsdesk
-
Apr 10, 2024, 8:16AM
Monday, April 08, 2024
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Benzinga Newsdesk
-
Apr 8, 2024, 8:55AM
Friday, April 05, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
Benzinga Newsdesk
-
Apr 5, 2024, 7:50PM
Wednesday, April 03, 2024
Palisade Bio Plans 1-For-15 Reverse Split Of Its Common Stock
Benzinga Newsdesk
-
Apr 3, 2024, 5:31PM
Wednesday, March 27, 2024
Palisade Bio Q4 EPS $(0.25) Beats $(0.34) Estimate
Happy Mohamed
-
Mar 27, 2024, 8:04AM
Tuesday, February 13, 2024
Palisade Bio Appoints Donald Williams As Chairman Of Board
Benzinga Newsdesk
-
Feb 13, 2024, 8:40AM
Tuesday, January 30, 2024
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Jan 30, 2024, 1:18PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Jan 30, 2024, 12:31PM
Palisade Bio Announces Exercise Of Previously Issued Warrants For $2.5M
Benzinga Newsdesk
-
Jan 30, 2024, 9:29AM
Monday, January 29, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Jan 29, 2024, 4:31PM
Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Jan 29, 2024, 2:09PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Jan 29, 2024, 12:31PM
Dow Edges Lower; Cardlytics Shares Jump
Avi Kapoor
-
Jan 29, 2024, 12:16PM
Why Is Gastrointestinal Disease-Focused Palisade Bio Stock Trading Higher Today?
Vandana Singh
-
Jan 29, 2024, 10:15AM
Palisade Bio Shares Halted On Circuit Breaker To The Downside, Stock Now Up 138.5%
Benzinga Newsdesk
-
Jan 29, 2024, 9:49AM
US Stocks Edge Higher; Amazon And iRobot Agree To Terminate Acquisition Deal
Avi Kapoor
-
Jan 29, 2024, 9:48AM
Palisade Bio shares are trading higher after the company requested the withdrawal of a recently filed registration statement. Also, the company announced preclinical data of its lead program PALI-2108 at the 2024 Crohn's & Colitis Congress.
Benzinga Newsdesk
-
Jan 29, 2024, 9:18AM
Palisade Bio Announced The Presentation Of Positive Preclinical Data Of Its Lead Asset, PALI-2108 At The Crohn's & Colitis Congress
Benzinga Newsdesk
-
Jan 29, 2024, 8:08AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Jan 29, 2024, 8:06AM
Why ZIM Integrated Shipping Services Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Jan 29, 2024, 7:56AM
Friday, January 26, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Jan 26, 2024, 4:31PM
Palisade Bio Requesting To Withdraw The Registration Statement And May Consider Subsequent Private Offerings Instead; Requests That Fees Paid To The Commission Be Credited For Future Registration Statements
Benzinga Newsdesk
-
Jan 26, 2024, 4:07PM
Monday, January 22, 2024
A Look Into Healthcare Sector Value Stocks
Benzinga Insights
-
Jan 22, 2024, 9:44AM
Tuesday, January 02, 2024
LumiraDx, Sacks Parente Golf And 3 Stocks To Watch Heading Into Tuesday
Avi Kapoor
-
Jan 2, 2024, 2:44AM
Friday, December 29, 2023
Palisade Bio Inc Files For Offering Of Shares Of Common Stock; Size Not Disclosed
Bill Haddad
-
Dec 29, 2023, 4:03PM
Thursday, December 28, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Dec 28, 2023, 8:06AM
Palisade Bio Announced The Receipt Of The Second Milestone Payment To Giiant From The U.S. Crohn's And Colitis Foundation
Benzinga Newsdesk
-
Dec 28, 2023, 8:03AM
Thursday, December 14, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Dec 14, 2023, 4:31PM
Friday, November 17, 2023
Maxim Group Upgrades Palisade Bio to Buy, Announces $1.5 Price Target
Benzinga Newsdesk
-
Nov 17, 2023, 7:58AM
Friday, November 10, 2023
Recap: Palisade Bio Q3 Earnings
Benzinga Insights
-
Nov 10, 2023, 9:10AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch